{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:19:13Z","timestamp":1790306353596,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T00:00:00Z","timestamp":1712966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z221100007922018"],"award-info":[{"award-number":["Z221100007922018"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z231100004823001"],"award-info":[{"award-number":["Z231100004823001"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ijid.2024.107060","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T03:14:13Z","timestamp":1714014853000},"page":"107060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The contributions of vaccination and natural infection to the production of neutralizing antibodies against the SARS-CoV-2 prototype strain and variants"],"prefix":"10.1016","volume":"144","author":[{"given":"Hui","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luodan","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengshuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2024.107060_bib0001","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2024.107060_bib0002","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2024.107060_bib0003","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ijid.2024.107060_bib0004","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/jmv.27643","article-title":"The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant","volume":"94","author":"Tian","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2024.107060_bib0005","first-page":"8012","article-title":"Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics","volume":"25","author":"Meo","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.ijid.2024.107060_bib0006","first-page":"838","article-title":"SARS-CoV-2 Omicron variant: characteristics and prevention","volume":"2","author":"He","year":"2021","journal-title":"Med"},{"key":"10.1016\/j.ijid.2024.107060_bib0007","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-022-04442-5","article-title":"Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron","volume":"603","author":"Shuai","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2024.107060_bib0008","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41586-022-04441-6","article-title":"SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters","volume":"603","author":"Halfmann","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2024.107060_bib0009","series-title":"Emergency Committee on the COVID-19 pandemic. Statement on the fifteenth meeting of the IHR","year":"2023"},{"key":"10.1016\/j.ijid.2024.107060_bib0010","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(23)00129-0","article-title":"Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis","volume":"401","author":"Pan","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2024.107060_bib0011","series-title":"major strain causing latest outbreak in Beijing, has strong infectious ability: medical expert","author":"Times","year":"2022"},{"key":"10.1016\/j.ijid.2024.107060_bib0012","doi-asserted-by":"crossref","first-page":"511","DOI":"10.46234\/ccdcw2023.096","article-title":"A comparison of clinical characteristics of infections with SARS-CoV-2 omicron subvariants BF.7.14 and BA.5.2.48 \u2013 China, October-December 2022","volume":"5","author":"Huo","year":"2023","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.ijid.2024.107060_bib0013","doi-asserted-by":"crossref","first-page":"143","DOI":"10.46234\/ccdcw2023.026","article-title":"Genomic surveillance for SARS-CoV-2 - China, September 26, 2022 to January 29, 2023","volume":"5","author":"Wang","year":"2023","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.ijid.2024.107060_bib0014","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41591-023-02212-y","article-title":"Estimating the transmission dynamics of SARS-CoV-2 Omicron BF.7 in Beijing after adjustment of the zero-COVID policy in November-December 2022","volume":"29","author":"Leung","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2024.107060_sbref0015","series-title":"COVID-19 Situation at a Glance","year":"2022"},{"key":"10.1016\/j.ijid.2024.107060_bib0016","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3390\/vaccines10101677","article-title":"Immune persistence against SARS-CoV-2 after primary and booster immunization in humans: a large-scale prospective cohort study","volume":"10","author":"Li","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.ijid.2024.107060_bib0017","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijid.2022.01.068","article-title":"Evaluation of immunogenicity by Pseudovirus neutralization assays for SARS-CoV-2 variants after primary and booster immunization","volume":"117","author":"Xie","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2024.107060_bib0018","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41392-023-01391-x","article-title":"Antigenic characterization of SARS-CoV-2 Omicron subvariants XBB.1.5, BQ.1, BQ.1.1, BF.7 and BA.2.75.2","volume":"8","author":"Zhu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ijid.2024.107060_bib0019","article-title":"Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection","volume":"33","author":"Chen","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.ijid.2024.107060_bib0020","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1473-3099(23)00010-5","article-title":"ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5","volume":"23","author":"Yue","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107060_bib0021","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1473-3099(22)00816-7","article-title":"Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB","volume":"23","author":"Uraki","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107060_bib0022","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJMc2202542","article-title":"Efficacy of a fourth dose of Covid-19 mRNA vaccine against omicron","volume":"386","author":"Regev-Yochay","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2024.107060_bib0023","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cell.2022.12.018","article-title":"Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ijid.2024.107060_bib0024","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41421-023-00569-5","article-title":"Neutralization of SARS-CoV-2 BQ.1.1, CH.1.1, and XBB.1.5 by breakthrough infection sera from previous and recent waves in China","volume":"9","author":"Wang","year":"2023","journal-title":"Cell Discov"},{"key":"10.1016\/j.ijid.2024.107060_bib0025","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1473-3099(23)00051-8","article-title":"Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant","volume":"23","author":"Uriu","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107060_bib0026","first-page":"e239","article-title":"The rapid rise of SARS-CoV-2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants","volume":"4","author":"Ao","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.ijid.2024.107060_bib0027","first-page":"521","article-title":"Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution","volume":"614","author":"Cao","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2024.107060_bib0028","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41591-022-02162-x","article-title":"Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster","volume":"29","author":"Kurhade","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2024.107060_bib0029","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2202263","article-title":"Omicron BA.1 breakthrough infections in inactivated COVID-19 vaccine recipients induced distinct pattern of antibody and T cell responses to different Omicron sublineages","volume":"12","author":"Guo","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ijid.2024.107060_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112075","article-title":"Durability of neutralization against Omicron subvariants after vaccination and breakthrough infection","volume":"42","author":"Zhu","year":"2023","journal-title":"Cell Rep"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224001310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224001310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T03:00:40Z","timestamp":1716951640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971224001310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":30,"alternative-id":["S1201971224001310"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107060","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contributions of vaccination and natural infection to the production of neutralizing antibodies against the SARS-CoV-2 prototype strain and variants","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107060"}}